menu
    • menu

    Company profile for Avenzo Therapeutics

    NEW Drugs in Dev: 5
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avenzo Therapeutics, established in 2022 and co-founded by Dr. Athena Countouriotis and Dr. Mohammad Hirmand, is a clinical-stage biotechnology firm. Our primary focus is on developing and advancing a robust pipeline of oncology therapies with the aim of being among the best in their class. These therapies are designed to target cell cycle control mechanisms, with the goal of halting the abnormal proliferation of cells that is...
    Avenzo Therapeutics, established in 2022 and co-founded by Dr. Athena Countouriotis and Dr. Mohammad Hirmand, is a clinical-stage biotechnology firm. Our primary focus is on developing and advancing a robust pipeline of oncology therapies with the aim of being among the best in their class. These therapies are designed to target cell cycle control mechanisms, with the goal of halting the abnormal proliferation of cells that is characteristic of many types of cancer. Our team boasts a proven track record within the industry for developing oncology treatments that hold promise in significantly impacting patients' lives for the better.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avenzo TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Suite 200, San Diego, CA 92130
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://avenzotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/avenzotx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avenzo Presents Updated AVZO-021 Study Results at ASCO
    Avenzo Presents Updated AVZO-021 Study Results at ASCO

    01 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260601127731/en/Avenzo-Therapeutics-Presents-Updated-Results-from-the-Phase-12-Study-of-AVZO-021-a-Potentially-Differentiated-CDK2-Inhibitor-at-the-2026-American-Society-of-Clinical-Oncology-Annual-Meeting

    BUSINESSWIRE
    01 Jun 2026
    Share Share
    Rallybio Finds A New Reverse-Merger Dance Partner In Avenzo
    Rallybio Finds A New Reverse-Merger Dance Partner In Avenzo

    01 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260531328050/en/Rallybio-Corporation-and-Avenzo-Therapeutics-Announce-Merger-Agreement-to-Advance-Next-Generation-Oncology-Therapies-and-%24215-Million-Concurrent-Private-Placement

    BUSINESSWIRE
    01 Jun 2026
    Share Share
    Avenzo Doses First Patient in CDK4/CDK2 Combo ORION-1 Study
    Avenzo Doses First Patient in CDK4/CDK2 Combo ORION-1 Study

    28 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260528789641/en/Avenzo-Therapeutics-Announces-First-Patient-Dosed-in-Combination-Cohort-Evaluating-CDK4-Selective-Inhibitor-AVZO-023-with-CDK2-Selective-Inhibitor-AVZO-021-In-Ongoing-Phase-12-ORION-1-Study

    BUSINESSWIRE
    28 May 2026
    Share Share
    Avenzo Advances Dual CDK4/CDK2 Combo in Breast Cancer Study
    Avenzo Advances Dual CDK4/CDK2 Combo in Breast Cancer Study

    28 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-28/avenzo-therapeutics-advances-the-combination-of-cdk4-selective-inhibitor-avzo-023-with-cdk2-select

    PHARMIWEB
    28 Apr 2026
    Share Share
    Avenzo Therapeutics To Unveil AVZO-021, Phase 1 Study Results
    Avenzo Therapeutics To Unveil AVZO-021, Phase 1 Study Results

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/avenzo-therapeutics-to-present-updated-results-from-the-phase-1-study-of-avzo-021-a-potential-best

    PHARMIWEB
    21 Apr 2026
    Share Share
    Avenzo Therapeutics Unveils AVZO-021 Data at SABCS 2025
    Avenzo Therapeutics Unveils AVZO-021 Data at SABCS 2025

    11 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251211085624/en/Avenzo-Therapeutics-Presents-Initial-Results-from-the-Phase-12-Study-of-AVZO-021-a-Potential-Best-in-Class-CDK2-Inhibitor-at-the-2025-San-Antonio-Breast-Cancer-Symposium

    BUSINESSWIRE
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search